NCT00199134View on ClinicalTrials.gov

FRAGRANCE Part A Safety: Study to Find a Genetic Signature of de Novo Resistance to Letrozole

PHASE2CompletedINTERVENTIONAL
Enrollment

49

Participants

Timeline

Start Date

November 30, 2004

Primary Completion Date

December 31, 2014

Study Completion Date

December 31, 2014

Conditions
Breast Cancer
Interventions
DRUG

Letrozole

Size of the tumor is followed

Trial Locations (1)

1000

Jules Bordet Institute, Brussels

Sponsors
All Listed Sponsors
collaborator

Feculdade de Medicina da Universidade de Sao Paulo - Brasil

OTHER

collaborator

Hospital de Clinicas de Porto Alegre

OTHER

collaborator

Hospital do Cancer, Sao Paulo

OTHER

lead

Jules Bordet Institute

OTHER